Point-of-care ultrasound–guided early decongestion and 6-month outcomes in patients hospitalized with acute decompensated heart failure on an internal medicine ward: a comparative cohort study
In a comparative cohort study of patients hospitalized with acute decompensated heart failure, a point-of-care ultrasound–guided early decongestion strategy was not associated with improved 6-month outcomes of death or heart failure readmission compared to standard care.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Heart failure is a condition where the heart struggles to pump enough blood to meet the body's needs. When this condition suddenly worsens, causing fluid to build up in the lungs and other tissues, it is called acute decompensated heart failure. This fluid buildup, known as congestion, is the primary reason patients end up in the hospital. Once they are admitted, doctors work to remove this excess fluid, often using powerful water pills called diuretics. The goal is to leave the hospital feeling dry and comfortable. However, doctors have long known that physical exams are not always perfect at detecting hidden fluid. A patient might look and feel better, yet still carry enough fluid to make them sick again soon after leaving. This "vulnerable phase" after discharge is a dangerous time, filled with high risks of returning to the hospital or dying.
To solve this problem, some doctors have started using a handheld ultrasound machine at the bedside to look directly at the fluid. They check two main things: the lungs for signs of water and a large vein in the abdomen called the inferior vena cava. If this vein is wide and does not squish down when the patient breathes, it suggests high pressure in the veins and a body full of fluid. The idea is that if a doctor can see this congestion clearly, they can give a stronger dose of medication right away to flush it out, potentially saving the patient from a future crisis. But does seeing the fluid and acting on it actually change the outcome for the patient?
A new study from a hospital in Istanbul, Turkey, set out to answer this question in a real-world setting. The researchers focused on patients treated on general internal medicine wards, a place where the patients are often older and have different health profiles than those in specialized heart centers. They compared two groups of patients. One group received a special strategy: when they arrived, a doctor used a bedside ultrasound to check the large vein in their abdomen. If the vein was wide and stiff, indicating significant fluid buildup, the patient immediately received a high dose of intravenous furosemide, a common diuretic, specifically 200 milligrams within the first 24 hours. The other group received the standard care that was already in place at the hospital, where doctors decided the dose based on their usual clinical judgment, which typically started with a lower dose of 100 milligrams.
The study followed 100 patients in total, with 50 in each group, though a few were excluded because their follow-up records were missing. The researchers tracked these patients for six months after they left the hospital. They were looking for the most serious outcomes: whether the patient died or had to be readmitted to the hospital specifically for heart failure. The results were surprising to those hoping for a clear win. The strategy of using the ultrasound to trigger a higher dose of medication did not lead to better results. In fact, the group that received the ultrasound-guided, high-dose treatment had a slightly higher rate of bad outcomes, with 54 percent experiencing death or readmission, compared to 40 percent in the standard care group. While this difference was not statistically large enough to be called a definitive failure of the method, it certainly did not show the improvement the researchers were hoping for.
The study also looked at other details, such as how much urine the patients produced and how long they stayed in the hospital. Despite the higher starting dose of medication in the ultrasound group, there was no significant difference in how much fluid the patients actually lost in the first day or over their entire stay. The length of time they spent in the hospital was also the same for both groups. The researchers noted that the patients in the ultrasound group were slightly different in some ways; they were less likely to have a specific type of heart failure where the heart muscle is weak, and they were less likely to be former smokers. However, even after adjusting for these differences, the ultrasound strategy still did not show a benefit.
This finding adds to a growing body of evidence that simply seeing the fluid and giving a bigger dose of medicine at the very beginning of a hospital stay may not be enough to change a patient's long-term fate. The researchers suggest that the problem might be the approach itself. In this study, the ultrasound was used only once, at the moment of admission, to decide on a single, fixed dose. Other studies that have shown promise used ultrasound repeatedly throughout the hospital stay to constantly adjust the treatment until the fluid was gone. The authors conclude that while ultrasound is a useful tool for seeing what is happening inside the body, using it just to give a one-time boost of medication does not appear to save lives or prevent readmissions in the general hospital setting. Before this method becomes a standard rule, more research is needed to see if using ultrasound to guide treatment over several days, rather than just once, can make a real difference.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.